hTERT promotes the invasion of telomerase-negative tumor cells in vitro

International Journal of Oncology

Volumn 35, Issue 2, 2009, Pages 329-336

  Yu, Song Tao ^a   Chen, Ling ^a   Wang, Hong Jin ^a   Tang, Xu Dong ^a   Fang, Dian Chun ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alternative lengthening of telomeres; Human telomerase reverse transcriptase; Invasion; Metastasis; Relative telomere length; U2OS

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; METASTASIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TELOMERE; WESTERN BLOTTING; CELL PROLIFERATION; FLOW CYTOMETRY; GENETICS; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE; TRANSFECTION;

EID: 69449099710     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000344     Document Type: Article

References (29)

1. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
2. Shay JW and Wright WE: Telomeres are double-strand DNA breaks hidden from DNA damage responses. Mol Cell 14: 420-421, 2004.
3. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
4. Collins K: The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol 7: 484-494, 2006.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
6. Stewart SA and Weinberg RA: Telomerase and human tumorigenesis. Semin Cancer Biol 10: 399-406, 2000.
7. Yang SM, Fang DC, Luo YH, Lu R, Yang JL and Liu WW: Determination of telomerase activity and its subunits in different gastric lesions. Chin J Cancer 20: 23-27, 2001.
8. Yang SM, Fang DC, Luo YH, Lu R, Battle PD and Liu WW: Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions. J Gastroenterol Hepatol 16: 876-882, 2001.
9. Chen L, Cheng T, Cai YG, Tang XD, Li JJ, Fang DC, Luo YH, Yu ST and Yang SM: Expression of hTERT and its associated genes in the tumorigenesis of gastric mucosa and its significance. Chin J Gastroenterol Hepatol 15: 443-447, 2006.
10. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997.
11. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.
12. Muntoni A and Reddel RR: The first molecular details of ALT in human tumor cells. Hum Mol Genet 14: R191-R196, 2005.
13. Tsai HJ, Huang WH, Li TK, Tsai YL, Wu KJ, Tseng SF and Teng SC: Involvement of topoisomerase III in telomere-telomere recombination. J Biol Chem 281: 13717-13723, 2006.
14. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE and Reddel RR: A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11: 217-225, 2005.
15. Chang S, Khoo CM, Naylor ML, Maser RS and DePinho RA: Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Gene Dev 17: 88-100, 2003.
16. Canela A, Martin-Caballero J, Flores JM and Blasco MA: Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 24: 4275-4293, 2004.
17. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB, Popescu NC and Weinberg RA: Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99: 12606-12611, 2002.
18. Sun BC, Huang Q, Liu SX, Chen MZ, Hawks CL, Wang LS, Zhang CH and Hornsby PJ: Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase. Cancer Res 64: 6144-6151, 2004.
19. Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG, Luo YH, Liang GP and Yang SM: Induction of anti-tumor immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. J Pathol 217: 685-692, 2009.
20. Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47, 2002.
21. Yang SM, Fang DC, Yang JL, Chen L, Luo YH and Liang GP: Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 17: 209-217, 2008.
22. Yang SM, Fang DC, Yang JL, Liang GP, Lu R, Luo YH and Liu WW: Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma. J Gastroenterol Hepatol 17: 1144-1152, 2002.
23. Zhang G, Long M, Wu ZZ and Yu WQ: Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol 8: 243-246, 2002.
24. Wu ZZ, Zhang G, Long M, Wang HB, Song GB and Cai SX: Comparison of the viscoelastic properties of normal hepatocytes and hepatocellular carcinoma cells under cytoskeletal perturbation. Biorheology 37: 279-290, 2000.
25. Smith LL, Coller HA and Roberts JM: Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5: 474-479, 2003.
26. Geserick C, Tejera A, Gonzalez-Suarez E, Klatt P and Blasco MA: Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25: 4310-4319, 2006.
27. Bollmann FM: The many faces of telomerase: emerging extratelomeric effects. Bioessays 30: 728-732, 2008.
28. Bagheri S, Nosrati M, Li S, Fong S, Torabian S, Rangel J, Moore DH, Federman S, Laposa RR, Baehner FL, Sagebiel RW, Cleaver JE, Haqq C, Debs RJ, Blackburn EH and Kashani-Sabet M: Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA 103: 11306-11311, 2006.
29. Yang JM, Peng ZH, Si SH, Liu WW, Luo YH and Ye ZY: KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models. Liver Int 1: 132-139, 2008.